Puregene, based in Switzerland, breeds genetically superior cannabis and hemp varieties developed using advanced artificial intelligence driven breeding technology and has one of the largest libraries of cannabis genetics in the world.
Switzerland is known for its quality and attention to detail and has one of the most mature low-THC cannabis markets in the world. By combining Swiss quality with their state-of-the-art breeding technology, Puregene is able to develop the best and most novel cannabis genetics in the industry and their Swiss philosophy is at the heart of every cross, selection, and experiment it carries out.
Puregene provides Felbridge with a secure development pipeline of high value novel cannabinoids which are fully compliant with local as well as international regulations and continues to focus on research and development in the sector and has established partnerships with many leading universities in Europe as well as in South Africa, where it conducts research-related activities with the University of Stellenbosch.
Felbridge has entered into a license and distribution agreement with Puregene to market their elite cannabis strains throughout Africa.
For more information on Puregene, visit www.puregene.com